- ISPOR Latin America Summit 2019
ISPOR Latin America 2019
- Exhibits & Sponsorship
ISPOR Europe 2019
- Abstract Submission
- Short Courses
- Exhibits & Sponsorship
ISPOR Summit 2019
- ISPOR 2019
- ISPOR Warsaw 2019
- ISPOR Europe 2018
- ISPOR Summit 2018
- ISPOR Dubai 2018
- ISPOR Asia Pacific 2018
- ISPOR 2018
- ISPOR Europe 2017
- ISPOR Latin America 2017
- ISPOR Asia Pacific 2016
- Submit Abstract
- Exhibits & Sponsorships
- Awards & Grants
- Upcoming Conferences
Education & Training
- In-Person Training
- Introduction to Outcomes Research
- Introduction to Systematic Reviews & Meta-Analysis
- Systematic Review & Meta-Analysis: Applications
- Introduction to Pharmacoeconomics
- Cost-of-Illness/Cost-Estimation (COI/CE)
- Cost-Minimization/Cost-Consequence (CMA/CCA)
- Cost-Effectiveness Analysis (CEA) and Cost-Utility Analysis (CUA)
- Modeling Health Care Costs – Part I: Characteristics of Health Care Costs
- Modeling Health Care Costs – Part II: Methods and Guidelines for Estimating Health Care Costs
- Modeling Health Care Costs – Part III: Estimation from Censored Data
- Introduction to Budget Impact Analysis (BIA) - Part I
- Introduction to Budget Impact Analysis (BIA) - Part II
- Markov Model Toolkit: Concepts, Assumptions and Examples
- An Introduction to Choice-Based Conjoint Analysis (Discrete Choice Experiments)
- Health-Related Quality of Life (HRQOL) – Basics
- Patient Reported Outcomes: Analysis and Interpretation
- Patient Reported Outcomes: Instrument Development
- Item Response Theory: A Conceptual Introduction
- Preparing for Multinational Clinical Trials: Translation and Cultural Adaptations of PRO Measures
- Evidence Generation for Patient Reported Outcome (PRO) Label Claims (FDA Requirements)
- Intermediate Retrospective Observational Study - Propensity Scoring Methods
- Use of Public Survey Data in Health Outcomes Research
- Using RWE to Improve Healthcare Decision-making in Asia Pacific
- Top 10 HEOR Trends of 2019
- The Use of MCDA for HTA Agencies
- MCDA - How to Guide of Different Methods for Assessment of Rare Disease HT
- Virtualizing Long-Term Follow-Up Studies for Gene Therapy Products
- Is the FDA's New Guidance a Watershed Moment for Real-world Evidence?
- Topics in Evaluating the Cost-Effectiveness of Gene Therapies
- Distance Learning
Special Interest Groups
- Digital Health
- Health Preference Research
- Medical Devices and Diagnostics
- Medication Adherence and Persistence
- Nutrition Economics
- Open Source Models
- Personalized / Precision Medicine
- Rare Disease
- Statistical Methods in HEOR
- Task Forces
Councils & Roundtables
- Faculty Advisor Council
- Global Engagement Council
- Health Science Policy Council
- Health Technology Assessment Council
- Institutional Council
- Past Presidents Council
- Patient Council
- Education Council
- Asia Consortium Founding Members
- Asia Consortium Executive Committee
- Asia Consortium Advisory Committee
- Asia Pacific Conference Committee
- Asia Consortium Education Committee
- Asia Consortium Publication Committee
- Asia Consortium Industry Committee
- Asia Consortium HTA Agencies Committee
- Central & Eastern Europe Consortium
- Latin America Consortium
- Asia Consortium
- Regional Chapters
Join an ISPOR Global Member Group
- Start a Student Chapter
- Apply For/Renew Membership
- Apply for a Student Travel Grant
- Student Council
- Student Chapters
- Student Chapter President Resource Center
- Student Network Committees
- Student Network Awards
- Student Newsletters
- Formulary Decisions
Professional Development Resources
- ISPOR & AACP Joint Webinar – “Tips for Securing a Post-Doctoral Fellowship”
- You Are Creative: Research is the First Step
- AMCP eDossier System @ FormularyDecisions.com Demo and Practical Application
- Good Practices for a Successful Job Search
- Leveraging The Power Of LinkedIn
- Internships & Fellowships: Career Opportunities for the Future
- My Career Path
- Career Advice Across the Globe
- "My ISPOR Story" - Zeba Khan
- "My ISPOR Story" - Lou Garrison
- Professional Development Resources
- Special Interest Groups
ISPOR’s mission is to promote health economics and outcomes research excellence to improve decision making for health globally. It seeks to improve healthcare decisions for all stakeholders, including researchers and academicians, assessors and regulators, payers and policy makers, the life sciences industry, healthcare providers, and patient engagement organizations.
ISPOR is also strongly committed to diversity. One of its core values is to, “strengthen the Society through encouragement and acceptance of diverse ideas, cultures, and disciplines.” The Society aims to reflect the diversity of its membership in all endeavors and encourages consideration of its diversity dimensions in abstract submissions. These include (but not limited to) gender, career stage, ethnicity, race, education, sexual orientation, region/geographic location, physical disability, and religion.
- Outcomes research on all health care interventions (including drugs, devices, behavioral modification programs, surgery, disease prevention, gene therapy, screening, diagnostic procedures, and health education) and on all diseases or methodologies are considered.
- Abstracts are evaluated on the quality of the study (or concept) and the quality of the presentation.
- Authors of accepted abstracts are required to transfer copyright to ISPOR.
- Abstracts that have been submitted to another conference and copyright has been transferred to another organization will not be considered.
- Research presented at a previous ISPOR meeting is not allowed.
- Accepted abstracts will be published as submitted in Value in Health. Changes to abstracts will not be accepted after the Submission Deadline; therefore, they should be carefully written and edited prior to submission. Please note that only presented research will be published in Value in Health.
- Accepted research is presented as a 15-minute podium presentation or a poster presentation with an author discussion hour.
- All podium presentations and the top 10% of poster presentations, based on peer review evaluation, are eligible for an ISPOR Research Presentation Award.
- Example of a research abstract submission is available here.
Below are instructions to assist with your research abstract submission. The submission process is geared to collect three aspects of your research: (1) Study Approach; (2) Relevant Topics/Subtopics; (3) Associated Specific Diseases/Specialized Treatment Areas.
STEP 1: TITLE
When submitting your abstract, titles must be submitted in all CAPS.
STEP 2: RESEARCH STUDY APPROACH
When submitting your abstract, you must identify the study approach of your research by selecting the most relevant approach from the list below. Please note if your research is a methods study or conceptual paper, you should choose the corresponding option below.
Study Approaches: Administrative Claims DataStudy Approaches: Clinical Trials
Study Approaches: Decision Modeling & Simulation
Study Approaches: Electronic Medical & Health Records
Study Approaches: Literature Review & Synthesis
Study Approaches: Meta-analysis & Indirect Comparisons
Study Approaches: Pragmatic Trials & Large Simple Trials
Study Approaches: Prospective Observational Studies
Study Approaches: Registries
Study Approaches: Surveys & Expert Panels
Does Not Apply (Conceptual Papers/Research on Methods)
STEP 3: TOPICS AND SUBTOPICS FOR RESEARCH SUBMISSIONS
When submitting your abstract, you must select at least one topic and subtopic that best describes your research. You may choose up to four topic/subtopics. Topic subcategories are listed after each topic below to aid in your selection. Please note that “Does Not Apply” should only be chosen for Conceptual Papers.
Comparative Effectiveness or Efficacy
Clinician Reported Outcomes
Clinician Outcomes Assessment
Relating Intermediate to Long-term Outcomes
Cost/Cost of Illness/Resource Use Studies
Budget Impact Analysis
Thresholds & Opportunity Cost
Trial-based economic evaluation
Work & Home Productivity - Indirect Costs
Value of Information
Novel & Social Elements of Value
Safety & Pharmacoepidemiology
Prevalence, Incidence, & Disease Risk Factors
Disease Classification & Coding
Approval & Labeling
Pricing Policy & Schemes
Reimbursement & Access Policy
Insurance Systems & National Health Care
Public Spending & National Health Expenditures
Coverage with Evidence Development & Adaptive Pathways
Health Disparities & Equity
Hospital and Clinical Practices
Pharmacist Interventions and Practices
Quality of Care Measurement
Disease Management (including optimization studies)
Treatment Patterns and Guidelines
Systems & Structure
Value Frameworks & Dossier Format
Decision & Deliberative Processes
Digital Health (includes HIT, mhealth, wearables)
Diagnostics & Imaging
Artificial Intelligence, Machine Learning, Predictive Analytics
Confounding, Selection Bias Correction, Causal Inference
Modeling & Simulation
PRO & Related Methods
Academic & Educational
Best Research Practices
Geographic & Regional (not for epidemiology or treatment evaluation studies of population subgroups)
Adherence, Persistence, & Compliance
Stated Preference & Patient Satisfaction
Health State Utilities
Patient-reported Outcomes & Quality of Life Outcomes
Patient Behavior and Incentives
Instrument Development, Validation, & Translation
Data Protection, Integrity, & Quality Assurance
Health & Insurance Records Systems
Distributed Data & Research Networks
Reproducibility & Replicability
STEP 4: PEER REVIEW TOPIC
When submitting your abstract, you must select a preferred topic for your research, which will be used to assign the appropriate peer reviewers to your submission.
STEP 5: PREFERRED SPECIFIC DISEASE/SPECIALIZED TREATMENT AREAS FOR RESEARCH SUBMISSIONS
Accepted research abstracts are grouped according to specific diseases/specialized treatment areas for poster presentation. Please indicate one specific diseases/specialized treatment areas below to assist in assigning your abstract for poster presentation. You can choose "Multiple" if one choice does not apply.
Please note you will have the opportunity to select additional specific diseases/specialized treatment areas to represent your research on the next submission step. This step will not apply if (1) your abstract is accepted for podium presentation or (2) your abstract is not accepted for presentation.
Cardiovascular Disorders (including MI, Stroke, Circulatory)
Diabetes/Endocrine/Metabolic Disorders (including obesity)
Infectious Disease (non-vaccine)
Injury & Trauma
Mental Health (including addition)
Musculoskeletal Disorders (Arthritis, Bone Disorders, Osteoporosis, Other Musculoskeletal)
Rare & Orphan Diseases
Reproductive & Sexual Health
Respiratory-Related Disorders (Allergy, Asthma, Smoking, Other Respiratory)
Sensory System Disorders (Ear, Eye, Dental, Skin)
Systemic Disorders/Conditions (Anesthesia, Auto-Immune Disorders (n.e.c.), Hematological Disorders (non-oncologic), Pain)
Biologics & Biosimilars
Genetic, Regenerative & Curative Therapies
Personalized & Precision Medicine
STEP 6: SPECIFIC DISEASE/SPECIALIZED TREATMENT AREAS FOR RESEARCH SUBMISSIONS
When submitting your abstract, you can select up to 4 specific diseases/specialized treatment areas that best describes your research. If no disease or multiple diseases apply to your abstract, select Multiple Diseases or No Specific Disease.
CRITERIA FOR EVALUATION OF RESEARCH ABSTRACTS:
QUALITY OF STUDY CRITERIA (FOR STUDY APPROACHES):
**Note: For studies involving data collection or analysis, the abstract will be REJECTED if RESULTS are NOT included.**
- Research design is appropriate & transparent.
- Data sources are appropriate & transparent.
- Data analyses are appropriate & transparent.
- Results ARE INCLUDED and are transparent and comprehensible.
- Conclusions are consistent with the results.
QUALITY OF CONCEPTUAL PAPER ABSTRACTS:
- Approach to concept is apparent.
- Sufficient background information is provided.
- Practical implications/recommendations are provided.
- Conclusions or recommendations are consistent with the goal of the abstract
QUALITY OF THE ABSTRACT PRESENTATION CRITERIA:
- Objectives/research questions are clearly stated and objectives are addressed.
- Factual information is kept separate from interpretations or implications/unbiased presentation.
- Implications/results, as presented, are easy to understand.
- Presentation appears unbiased and is not promoting a product or service.
RESEARCH TOPIC IMPORTANCE
- Please rate the importance of this subject to be included in this year’s scientific program.